A Study About Nutritional Support of Enhanced Protein in Critical Patients
A Multicenter Randomized Controlled Clinical Study With WeiYuan Tai (a Nutritional Supplement) on Nutritional Support of Enhanced Protein in Severe Patients(Tai Shan)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Wei Chen
- Phone Number: +86(010)69154095
- Email: chenw@pumch.cn
Study Contact Backup
- Name: Zhangping Yu
- Phone Number: +86(010)69154095
- Email: yuzhangping1993@163.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosed as critical illness, stayed in ICU;
- score of M-nutric ≥ 5;
- score of 3. APACHE Ⅱ >12;
- anticipation of length of hospital stay > 6 days;
- 18 ≤ age ≤ 45;
- pattens volunteer to attend this study and sigh the inform consent form;
Exclusion Criteria:
- liver function(AST/ALT) of blood test ≥ 2.5 ULN(upper limit of normal); renal function of blood test > 1.6 ULN;
- the patients are used or are planned to use the Human Albumin solution within 3 days before receiving enteral nutrition;
- consume any natural food or something made by natural food;
- patients are used or are planned to use all-in-one solution or amino acid solution within 3 days before receiving enteral nutrition;
- anticipation of survival time is less than 5 days;
- have the contraindications of enteral nutrition;
- patients are allergic to material of the production;
- patients who are considered not suitable for this study by investigators;
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: control group
Patients will be given basic energy intake according to their weight, and will be extra maltodextrin as the placebo
|
supplement as basic energy intake
used as placebo in the control group
|
|
Experimental: intervention group
Patients will be given basic energy intake according to their weight, and will be extra protein intake
|
supplement as basic energy intake
patients will be given extra protein intake except the basic energy intake
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
urea nitrogen of 24h
Time Frame: day6
|
the total amount of urea nitrogen in 24 hours
|
day6
|
|
prealbumin(PA)
Time Frame: day6
|
the level of prealbumin in blood
|
day6
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
total protein
Time Frame: day6
|
the total protein level in blood
|
day6
|
|
albumin
Time Frame: day6
|
the level of albumin in blood
|
day6
|
|
calf circumference
Time Frame: change from baseline calf circumference at 6 days
|
the perimeter of calf
|
change from baseline calf circumference at 6 days
|
|
grip
Time Frame: change from baseline grip at 6 days
|
the strength(force measured kilograms) of the right hand measured by a hand-held dynamometer (if the right hand is not impossible, the left is ok )
|
change from baseline grip at 6 days
|
|
overall complication rate
Time Frame: from the day receiving enteral nutrition to day6
|
the over complication rate after receiving enteral nutrition
|
from the day receiving enteral nutrition to day6
|
|
length of hospital stay
Time Frame: from date of admission in the hospital until the date of discharge, up to 1 year
|
the overall time stay in hospital
|
from date of admission in the hospital until the date of discharge, up to 1 year
|
|
cost in hospital
Time Frame: from date of admission in the hospital until the date of discharge, up to 1 year
|
all the money paid in the hospital
|
from date of admission in the hospital until the date of discharge, up to 1 year
|
|
liver function
Time Frame: day6
|
the level of AST/ALT in blood
|
day6
|
|
renal function
Time Frame: day6
|
the level of creatinine in blood
|
day6
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Wei Chen, Peking Union Medical College Hospital
Publications and helpful links
General Publications
- Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, Hiesmayr M, Mayer K, Montejo JC, Pichard C, Preiser JC, van Zanten ARH, Oczkowski S, Szczeklik W, Bischoff SC. ESPEN guideline on clinical nutrition in the intensive care unit. Clin Nutr. 2019 Feb;38(1):48-79. doi: 10.1016/j.clnu.2018.08.037. Epub 2018 Sep 29.
- Arabi YM, Al-Dorzi HM, Mehta S, Tamim HM, Haddad SH, Jones G, McIntyre L, Solaiman O, Sakkijha MH, Sadat M, Afesh L, Kumar A, Bagshaw SM, Aldawood AS; PermiT Trial Group. Association of protein intake with the outcomes of critically ill patients: a post hoc analysis of the PermiT trial. Am J Clin Nutr. 2018 Nov 1;108(5):988-996. doi: 10.1093/ajcn/nqy189.
Study record dates
Study Major Dates
Study Start (Anticipated)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- HS-2028
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.